Challenges and opportunities in NASH drug development
Stephen A. Harrison, Alina M. Allen, Julie Dubourg, Mazen Noureddin, Naim Alkhouri
Topics & Concepts
Drug developmentClinical trialNonalcoholic steatohepatitisMedicineIntensive care medicineNonalcoholic fatty liver diseaseDrugClinical endpointDiseaseDrug trialPathologyFatty liverPharmacologyLiver Disease Diagnosis and TreatmentHepatitis C virus researchLiver Diseases and Immunity